Hypoxia-inducible factor-1α polymorphisms and TSC1/2 mutations are complementary in head and neck cancers
<p>Abstract</p> <p>Background</p> <p>Polymorphisms or mutations in hypoxia inducible factor-1 alpha (HIF-1alpha) that increases its activity and stability under normoxia have recently been identified. Likewise, disruption of the TSC1/TSC2 complex through loss of TSC1 or...
Main Authors: | Nikitakis Nikolaos G, Ord Robert A, Parashar Pallavi, Norris Kathleen, Hebert Carla, Sauk John J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-01-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/5/1/3 |
Similar Items
-
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
by: Nikitakis Nikolaos, et al.
Published: (2007-01-01) -
Sulindac Induces Apoptosis and Inhibits Tumor Growth In Vivo in Head and Neck Squamous Cell Carcinoma
by: Mark A. Scheper, et al.
Published: (2007-03-01) -
Hypoxia in head and neck cancer
by: Winter, Stuart Charles Alec
Published: (2005) -
Correlation between hypoxia-inducible factor-1α C1772T/G1790A polymorphisms and head and neck cancer risk: a meta-analysis
by: Ting Wu, et al.
Published: (2021-07-01) -
Mucin 1 regulates the hypoxia response in head and neck cancer cells
by: Kusumawadee Utispan, et al.
Published: (2021-12-01)